The global Bone Graft Substitutes Market is valued at USD 4.04 Billion in 2024 and is projected to reach a value of USD 8.26 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 6.75% between ...

"Trivium represents a significant advancement in bone grafting technology," said Sean Browne, President and CEO of Xtant Medical. "By combining enhanced composition, high BMP retention, and ...